,address1,city,state,zip,country,phone,fax,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,pegRatio,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Dr. Frank H. Laukien Ph.D.', 'age': 62, 'title': 'Chairman, CEO & Pres', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 1815797, 'exercisedValue': 3253255, 'unexercisedValue': 3711934}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
1,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Mr. Gerald N. Herman', 'age': 64, 'title': 'Exec. VP & CFO', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 858088, 'exercisedValue': 0, 'unexercisedValue': 1158492}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
2,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Dr. Mark R. Munch Ph.D.', 'age': 60, 'title': 'Corp. Exec. VP and Pres of Bruker Nano Group & Corp.', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1439963, 'exercisedValue': 0, 'unexercisedValue': 5231391}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
3,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Mr. Juergen  Srega', 'age': 67, 'title': 'Pres of Bruker CALID Group & Bruker Daltonics Division', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 646991, 'exercisedValue': 0, 'unexercisedValue': 1797473}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
4,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Dr. Falko  Busse Ph.D.', 'age': 55, 'title': 'Pres of Bruker BioSpin Group', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 763337, 'exercisedValue': 0, 'unexercisedValue': 1224745}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
5,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Mr. Justin Joseph Ward', 'title': 'Sr. Director of Investor Relations & Corp. Devel.', 'exercisedValue': 0, 'unexercisedValue': 0}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
6,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Mr. J. Brent Alldredge J.D.', 'age': 47, 'title': 'Gen. Counsel & Sec.', 'yearBorn': 1975, 'exercisedValue': 0, 'unexercisedValue': 0}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
7,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Stacey  Desrochers', 'title': 'Treasurer & Director of Investor Relations', 'exercisedValue': 0, 'unexercisedValue': 0}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
8,40 Manning Road,Billerica,MA,01821,United States,978 663 3660,978 663 5585,https://www.bruker.com,Medical Devices,Healthcare,"Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",8525,"{'maxAge': 1, 'name': 'Dr. Burkhard  Prause', 'age': 55, 'title': 'Pres and CEO of Bruker Energy & Supercon Technologies, Inc.', 'yearBorn': 1967, 'fiscalYear': 2012, 'exercisedValue': 0, 'unexercisedValue': 0}",7,7,3,4,5,1693526400,1672444800,86400,2,60.0,63.0,63.0,63.0,60.0,63.0,63.0,63.0,0.19,0.003,1693440000,0.0926,0.32,1.126901,31.034483,28.251122,10,10,16,11,11,62.0,62.5,60000,60000,9251738624,50.5,76.0,3.408266,61.98,66.02,0.2,0.0033333334,EUR,9952945152,0.11755,98657382,146852992,0.32369998,0.71851,8.386,7.5125213,1672444800,1703980800,1688083200,0.154,319100000,2.03,2.23,2.61,3.667,17.116,FRA,EQUITY,BKD.F,BKD.F,"BRUKER CORP.  DL -,01",Bruker Corporation,1057644000,Europe/Berlin,CEST,7200000,63.0,100.0,68.0,84.36,85.0,2.2,buy,11,591699968,4.029,581500032,1261500032,1.136,2.078,2714500096,99.913,18.447,0.08371,0.28570998,1307000000,158762496,341500000,0.179,0.159,0.51645,0.21422,0.17867,USD,
